Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A new topical compound for hair loss, claimed to be developed by Jeff Vincint, is being discussed. It reportedly doesn't use minoxidil or finasteride, and there is skepticism about its legitimacy.

The user switched to oral Dutasteride, added RU58841, and used Ketoconazole-enriched Minoxidil but still experiences scalp itch and hair loss after 4 months. They are advised to give Dutasteride more time, consider seeing a dermatologist, and explore other topical solutions.

The conversation discusses the differences between KB solution and PG + Ethanol solution for RU58841 in treating hair loss. It compares the effectiveness and properties of these two solutions.

Topical finasteride is believed to reduce scalp DHT more than oral forms, but its effectiveness is questioned due to inconsistent application and absorption. Oral finasteride is considered more effective because it consistently reduces systemic DHT, ensuring more reliable results.

PP405 is the most promising future treatment for hair loss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hair loss and minoxidil to stimulate growth.

The conversation discusses scalp issues, with the original poster experiencing itchiness and a white layer on the scalp despite using ketoconazole shampoo. Suggestions include using rosemary oil for moisturizing and trying a hair serum to reduce flakes.

PP405 and GT20029 are new hair loss treatments with different mechanisms from traditional options like Minoxidil and Finasteride. PP405 targets hair follicle stem cells to reactivate growth, while GT20029 works as an androgen receptor deleter, both requiring ongoing use for effectiveness.

PP405 is a new hair growth stimulant different from Minoxidil, currently in phase 2 trials. Users discuss its potential, safety concerns, and the long wait before it might be available.

A 41-year-old man experienced significant hair regrowth using topical finasteride (0.025%), minoxidil, microneedling every two weeks, and occasional Nizoral 2% shampoo. He advises against using creatine due to personal experience with increased hair shedding.

The conversation discusses the less impressive results of Pyrilutamide (kx-836) in phase 3 compared to phase 2, with a suggestion that a longer study might show more significant results. One user reports personal success with Pyrilutamide, experiencing no further hair loss and gradual regrowth.

Using hair fibers daily is generally fine, but it's important to choose a quality keratin-based product to avoid scalp irritation. The user combines hair fibers with a regimen of finasteride, minoxidil, microneedling, and ketoconazole.

The user added witch hazel to their routine with finasteride and topical minoxidil to reduce scalp itching and potentially help with hair loss. They find witch hazel affordable and effective for itch relief, though its impact on hair loss is still uncertain.

The post and conversation discuss KX-826 (pyrilutamide) for hair loss treatment, with positive remarks about its advertising and authenticity in China. The user changed their perspective after further research and seeing genuine advertising.

The conversation discusses hair regrowth using finasteride 0.5mg and ketoconazole shampoo over four months, with no negative effects. The user shares a photo asking if the new growth is baby hairs, and another user encourages them to continue the routine.

The user is seeking a gentle, fragrance-free daily shampoo for a sensitive scalp with mild psoriasis, considering options like Cleure, CeraVe, and Vanicream. They are also contemplating using Nizoral once a week despite concerns about its harshness.

PP405 shows promising results for hair growth, potentially outperforming finasteride without side effects like erectile dysfunction. Users discuss using treatments like minoxidil, pyrilutamide, nizoral, and alfatradiol while waiting for PP405's availability.

The conversation is about finding effective hair loss shampoos with active ingredients like ketoconazole, caffeine, saw palmetto, or zinc pyrithione. The user seeks recommendations on effective products, side effects, scalp sensitivity, and usage frequency.

Stemoxydine is no longer available on Amazon in the US, and users discuss alternatives for making topical finasteride. OP cannot use minoxidil due to side effects and seeks other solutions.

PP405 shows promise in regenerating hair by activating dormant follicles. Other treatments like VDPHL01 and Breezula are also advancing, providing new hope for hair loss solutions.

RU58841 is more effective when mixed with isopropyl alcohol instead of minoxidil, as water in minoxidil degrades RU58841. Applying RU58841 separately from minoxidil, with an hour gap, enhances hair growth results.

Minoxidil can be used with isopropyl alcohol to create topical spironolactone. Spironolactone may dissolve better in ethanol or propylene glycol.

RU58841 is being considered for hair maintenance by someone who can't tolerate finasteride. Alternatives like topical finasteride, dutasteride, and KX826 are also suggested.

The conversation discusses recommendations for using topical melatonin for hair loss treatment. It also mentions Minoxidil, finasteride, and RU58841 as other treatments.

The user is using finasteride 1.25mg three times a week for hair regrowth and reports no significant side effects except watery semen initially. They also use a local caffeine shampoo and are considering haircuts to improve appearance.

OP is looking for ethanol to make a topical finasteride solution for hair loss treatment. Users suggest using Everclear or Spirytus as alternatives for ethanol.

The user has been using oral Dutasteride, RU58841, and Minoxidil for three years without success and is considering adding topical Finasteride or Dutasteride to target DHT both locally and systemically. Other users suggest sticking to a consistent treatment plan, exploring different combinations, and considering other factors like potential misdiagnosis or inconsistent medication use.

A woman with androgenic hair loss, likely due to PCOS, is seeking topical treatments as oral medications are not an option. Suggested treatments include topical finasteride, spironolactone, and clascoterone, with spironolactone and clascoterone being safer options due to lower systemic absorption risk.

A user with mild psoriasis on the scalp is using finasteride, topical minoxidil, and dermarolling for hair loss but plans to stop minoxidil on the crown due to psoriasis aggravation. Suggestions include switching to a lipid-based minoxidil, using Ketoconazole shampoo, or trying oral minoxidil.

The FDA warned that topical finasteride can cause serious side effects like sexual dysfunction and brain fog, similar to oral finasteride. Compounded topical formulations pose additional risks due to lack of regulation.

The conversation is about identifying the vehicle used in the Breezula (clascoterone) trial for hair loss. No specific treatments were mentioned.